Amid Mounting Concerns Over Victoza Problems, Sales Disappoint
Novo Nordisk reports that first quarter sales for Victoza are up about 80% from last year, but the relatively new diabetes drug failed to beat sales from the prior quarter…
Novo Nordisk reports that first quarter sales for Victoza are up about 80% from last year, but the relatively new diabetes drug failed to beat sales from the prior quarter…
A recent petition filed to remove Victoza from the market is groundless, according to Novo Nordisk, and the manufacturer of the diabetes drug indicates that it does not expect that…
A petition has been filed with the FDA by the prominent consumer advocacy group Public Citizen, calling for a Victoza recall to be issued to protect diabetics from exposure to…
According to federal drug regulators, Merck failed to conduct requested testing on their popular diabetes drugs Januvia and Janumet, which was designed to review the potential impact of the medications…
As many as 20% of doctors may shy away from prescribing Byetta or Januvia due to a possible increased risk of pancreatitis and pancreatic cancer, according to new research.
Medtronic’s Infuse bone graft product could be linked to an increased risk of cancer, according to the findings of a new study.
The findings of new research suggest that the popular diabetes drugs Byetta and Januvia could increase the risk of pancreatitis and pancreatic cancer.
Federal drug safety reviewers say that the side effects of Byetta, a diabetes drug, may share thyroid cancer concerns of similar medications, which may result in black-box warning for a…
A lawsuit has been filed against Eli Lilly & Co. and Amylin Pharmaceuticals by a woman who says side effects of Byetta caused her husbands death from liver and pancreatic…